Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Seattle Genetics and Spirogen prepare novel pyrrolobenzodiazepines

May 9, 2013

Yale University discloses new HIV reverse transcriptase inhibitors

May 8, 2013

FDA expands approval of efavirenz to patients as young as 3 months

May 6, 2013

Shionogi & Co. discloses new HIV integrase inhibitors

May 6, 2013

Ascletis Pharmaceuticals obtains rights to HIV drug in China

May 3, 2013

Gilead receives FDA complete response letters for elvitegravir and cobicistat

April 30, 2013

Japan Tobacco subsidiary set to launch novel anti-HIV combination tablet in Japan

April 25, 2013

Preclinical data reported for a novel HIV integrase inhibitor

April 15, 2013

Theratechnologies and Ferrer end tesamorelin agreement

April 9, 2013

Ferumoxytol-enhanced MRI shows potential for neuroimaging of patients with HAND

April 8, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...